Your session is about to expire
← Back to Search
Collaborative Care Enhancement for Mental Health (BHIP-CCM Trial)
N/A
Recruiting
Led By Sara J. Landes, PhD MA BA
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-facilitation (8 months after start of implementation facilitation) and post-sustainment (12 months after post-facilitation)
Awards & highlights
BHIP-CCM Trial Summary
This trial aims to help mental health teams adopt more collaborative care practices to improve care for patients.
Who is the study for?
This trial is for veterans receiving care from Behavioral Health Interdisciplinary Program (BHIP) teams at certain medical centers. It includes those treated for mental health issues, except patients with a dementia diagnosis. Clinicians working on BHIP Teams are also part of the study.Check my eligibility
What is being tested?
The project tests two strategies to improve outpatient mental health care: centralized technical assistance and implementation facilitation. The goal is to make team practices align better with collaborative chronic care models.See study design
What are the potential side effects?
Since this trial focuses on improving healthcare processes rather than testing drugs, it does not have typical medication side effects. However, changes in care may affect patient satisfaction or outcomes.
BHIP-CCM Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ primary comparison will be between pre-implementation facilitation and post-implementation facilitation (8 months after the pre-implementation administration).
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~primary comparison will be between pre-implementation facilitation and post-implementation facilitation (8 months after the pre-implementation administration).
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Mental health hospitalization rate among Veterans treated within each BHIP team.
Role Clarity and Team Primacy subdomains of the Team Development Measure (TDM)
Secondary outcome measures
All-cause mortality
Treatment cost
Treatment costs and hospitalization data compared to non-intervention sites
BHIP-CCM Trial Design
4Treatment groups
Experimental Treatment
Group I: Wave 4Experimental Treatment2 Interventions
Study design is a stepped wedge; Wave 4 begins by receiving Centralized Technical Assistance before crossing over to Implementation Facilitation
Group II: Wave 3Experimental Treatment2 Interventions
Study design is a stepped wedge; Wave 3 begins by receiving Centralized Technical Assistance before crossing over to Implementation Facilitation
Group III: Wave 2Experimental Treatment2 Interventions
Study design is a stepped wedge; Wave 2 begins by receiving Centralized Technical Assistance before crossing over to Implementation Facilitation
Group IV: Wave 1Experimental Treatment1 Intervention
Study design is a stepped wedge; Wave 1 begins by receiving Implementation Facilitation
Find a Location
Who is running the clinical trial?
US Department of Veterans Affairs Office of Mental Health and Suicide PreventionUNKNOWN
VA Office of Research and DevelopmentLead Sponsor
1,621 Previous Clinical Trials
3,307,501 Total Patients Enrolled
14 Trials studying Mental Health
2,278 Patients Enrolled for Mental Health
Sara J. Landes, PhD MA BAPrincipal InvestigatorCentral Arkansas Veterans Healthcare System Eugene J. Towbin Healthcare Center, Little Rock, AR
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My treatment site will decide the support method.
Research Study Groups:
This trial has the following groups:- Group 1: Wave 3
- Group 2: Wave 1
- Group 3: Wave 2
- Group 4: Wave 4
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger